Abstract Three patients (males, black, ages 37, 40 and 57) 
Human T-cell lymphotropic virus, type I (HTLV-I) is associated to a neoplastic disorder (Adult T-cell Leukemia and Lymphoma-ATLL), to a characteristic uveitis and a neurological chronic disease, Tropical Spastic Paraparesis or HTLV-I Associated Myelopathy (TSP/HAM). This condition is a chronic myelopathy without spontaneous remission, characterized by a slowly progressive paraparesis, affecting mainly the pyramidal tracts and associated to a variable sphincter disturbance and abnormalities of the sensory system 5 6 . In general, TSP/HAM occurrence follows the same geographical distribution of the virus, presenting high frequencies in Asia, West Indies, America, and Melanesia
10
, it affects predominantly individuals from 35 to 49 years of age, with a male/female ratio of 2.5 to 3.0:1, and shows a high frequency among Negroes, mixed race and Asians, although it has also been found among Caucasians 9 12 . In Brazil, the first cases of proven TSP/HAM were reported in 1989 2 4 . Furthermore, clinical and seroepidemiological studies have shown cases of TSP linked to HTLV-I antibody detection, in Recife, Salvador, Rio de Janeiro, Sao Paulo and Porto Alegre 1 8 .
The present work describes, for the first time, in Belém, Pará (Brazil), a positive association of HTLV-I with three cases of chronic myelopathy.
MATERIAL AND METHODS
Patients examined. Three patients attending a university outpatient clinic (at the Betina Souza e Ferro Hospital, UFPA) with complaints of chronic gait disturbances of obscure origin for more than 6 months, were neurologically examined. In addition, nine other relatives of two of the patients were examined in order to detect clinical signs of neurological abnormalities. Demographic data regarding these patients are presented in Table 1 . Serological assays. Serum samples were collected from all three patients and nine of their relatives. Serological diagnostic tests were provided and included an enzyme immunoassay (EIA, Ortho Diagnostic, USA) and a discriminative Western blot (Genelab 2.4, Singapore) that was capable of distinguishing serological reactivity between HTLV-I and HTLV-II, as previously described 7 .
RESULTS

Clinical features.
The clinical features of the three patients during medical examination and counseling are summarized in Tables 2 and 3 , and they presented a neurological disorder clinically diagnosed as Tropical Spastic Paraparesis. None of the examined relatives displayed any sign or symptom compatible with TSP/ HAM or any minor neurological abnormalities. Serological assay. All three patients showed antibodies reactive to HTLV-I/II when tested using the EIA. Western blot serological reactivity was confirmed 
DISCUSSION
The association of HTLV-I to a progressive neuroencephalopathy has been constantly described in Brazil since the initial detection in 1989 1 2 3 4 . The clinical and epidemiological data observed to date, appears to be similar to the cases of TSP/HAM described worldwide 11 12 . In the present paper three cases of clinically diagnosed myelopathy were described with characteristic symptoms of lower limb paresthesis and weakness, incapacity of walking, diminished deep reflexes, bilateral Babinski's sign, back pain, bladder dysfunction and impotence. The three patients fulfilled the clinical criteria as well as presenting serological evidence of HTLV-I infection, sufficient to categorize these as cases of TSP/HAM.
Epidemiological and demographic information also coincide with what is usually observed elsewhere; in that they were black males, with an age range of 37 to 57 years. The patients resided outside large urban areas, lacking in adequate clinical and laboratory facilities. The association of subtle symptoms at onset of disease, poor diagnostic resources and low income are common and complicating factors that contribute towards the absence of other cases described in the northern region of the Country.
Screening for the presence of antibodies to HTLV among nine relatives of patients 1 and 3 showed that patient 3 was the sole case in the family and transmission of the virus occurred possibly through the parenteral or sexual path. The wife and son (8 years of age) of patient 1 showed evidence of HTLV infection and vertical transmission had probably occurred.
As far as we are aware, these are the first cases of a proven association between HTLV-I and myelopathy (TSP/HAM) described in Belem, but the occurrence of this or other neurological disorders related to HTLV-I are probably more common. The dissemination of proper information for the clinical and laboratory procedures should be sufficient to improve diagnostic skills, however it is necessary to emphasize the need for a close surveillance and to undertake a further active search for cases of neurological diseases associated to HTLV-I, in this particular geographical region of the Country.
